Checkpoint Therapeutics's market cap is currently $158.71M. The company's EPS TTM is $-1.441; its P/E ratio is ―; Checkpoint Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 103.00K	$ 192.00K	$ 268.00K	$ 1.07M	$ 1.71M
Gross Profit	$ -43.46M	$ -49.63M	$ -48.19M	$ -15.28M	$ -17.62M
Operating Income	$ -52.15M	$ -58.33M	$ -56.72M	$ -23.20M	$ -24.85M
EBITDA	$ -52.15M	$ -58.33M	$ -56.72M	$ -23.20M	$ -24.85M
Net Income	$ -51.85M	$ -66.92M	$ -56.62M	$ -22.96M	$ -24.58M
Balance Sheet
Cash & Short-Term Investments	$ 4.93M	$ 12.07M	$ 54.73M	$ 40.77M	$ 26.08M
Total Assets	$ 5.38M	$ 13.29M	$ 55.73M	$ 42.60M	$ 26.97M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -4.93M	$ -12.07M	$ -54.73M	$ -40.77M	$ -26.08M
Total Liabilities	$ 18.43M	$ 32.77M	$ 25.98M	$ 7.22M	$ 8.12M
Stockholders' Equity	$ -13.05M	$ -19.48M	$ 29.75M	$ 35.38M	$ 18.85M
Cash Flow
Free Cash Flow	$ -47.59M	$ -57.55M	$ -26.31M	$ -16.55M	$ -21.37M
Operating Cash Flow	$ -47.59M	$ -57.55M	$ -26.31M	$ -16.55M	$ -21.37M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 40.45M	$ 14.89M	$ 40.27M	$ 31.25M	$ 25.45M

Currency in USD

Checkpoint Therapeutics Earnings and Revenue History

Income Statement >

Checkpoint Therapeutics Debt to Assets

Balance Sheet >

Checkpoint Therapeutics Cash Flow

Cash Flow >

Checkpoint Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing